Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98 (Q46389190)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98 |
scientific article |
Statements
1 reference
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98 (English)
1 reference
1 reference
1 reference
1 reference
Giuseppe Viale
1 reference
Nicolas Sirtaine
1 reference
Fanny Piette
1 reference
Roberto Salgado
1 reference
Françoise Van Eenoo
1 reference
Ghizlane Rouas
1 reference
John P A Crown
1 reference
Erika Hitre
1 reference
Emmanuel Quinaux
1 reference
Martine J Piccart
1 reference
Christos Sotiriou
1 reference
22 January 2013
1 reference
31
1 reference
7
1 reference
860-867
1 reference